Current Issue

September-October 2011 Contents

Drug Manufacturing

  • Drug counterfeiting: Under siege

    by Raymond Foo

    Asia’s pharmaceutical supply chains are constantly being invaded by fake and sub-standard drugs.

  • Moving up the compliance curve

    by Raymond Foo

    How does a company move compliance from a traditional approach to a fully effective quality system that is not only compliant but effi cient and integrated to key business processes? The following case study illustrates its transformation.

    • Editor's Note

    • The other drug problem

      by Raymond Foo

      There is a new front in the war on drugs, and it's not the kind of drugs one might think.

      • Drug Development

      • Surviving difficult times

        by Raymond Foo

        While the global recession has exacerbated fi nancial pressures on biopharmaceutical companies, those pressures create opportunities for the industry to reexamine and revamp the drug development process.

        • Special Report

        • Modern drug testing

          by Raymond Foo

          TÜV SÜD PSB is equipped with modern analytical testing equipments to help companies meet the necessary product quality and validation requirements for drugs and pharmaceutical products. Pharma Asia visited the facility in Singapore to fi nd out more.

          • Product Focus

          • High resolution data

            by Raymond Foo

            Agilent Technologies Inc introduced the SureScan Microarray Scanner, the latest innovation in scanner technology and the foundation of Agilent’s complete microarray solution for both gene expression and CGH/cytogenetics research applications.

            • Country Analysis